TrialDiabetes, obesity & metabolism2012

Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adults.

C D Gibson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.